EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research progress on active ingredients of traditional Chinese medicine in the treatment of asthenozoospermia

Hongyu Wang, Haichao Ge, Chunyan Ge, Lianwen Zheng, Lianhai Jin, Donghai Zhao

Frontiers in Reproductive Health · 23.04.2026 · 8

DOI: 10.3389/frph.2026.1837460 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Reproductive Health, online erschienen am 23.04.2026. Verfasst von Hongyu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Skills Experiment Center, Jilin Medical University, Jilin, China. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthenozoospermia, a main cause of male infertility, is characterized by diminished sperm motility and increased morphological abnormalities, presenting a major barrier to natural conception. While current treatments provide limited benefit, their effectiveness is often variable, invasive, and costly. In contrast, Traditional Chinese Medicine (TCM), guided by holistic principles and syndrome differentiation, offers a distinct therapeutic approach. Through multi-component, multi-target, and multi-pathway actions, TCM herbal compounds demonstrate considerable potential to improve sperm quality and address core pathological mechanisms of asthenozoospermia. This review systematically summarizes the therapeutic potential of four major classes of TCM active ingredients—flavonoids, polysaccharides, saponins, and phenols—in the management of asthenozoospermia. We elucidate their underlying molecular mechanisms, particularly focusing on the modulation of oxidative stress and inflammatory pathways. Furthermore, this review discusses current limitations of TCM in this area, addresses a knowledge gap regarding TCM active components for asthenozoospermia, and offers a reference for future research.

Schlagwörter

Stichwörter der Autor:innen

antioxidant stressasthenozoospermiamulti-target therapyreproductive pharmacologytraditional Chinese medicine extracts

Autor:innen und Institutionen

  • Clinical Skills Experiment Center, Jilin Medical University, Jilin, China.
  • Department of Gastroenterology, the First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
  • Department of Pediatric Surgery, Taizhou Hospital, Taizhou, Zhejiang, China.
  • Department of Obstetrics and Gynecology, the Second Hospital of Jilin University, Changchun, Jilin, China.
  • College of Basic Medicine, Jilin Medical University, Jilin, China.

Zitieren

APA

Wang, H., Ge, H., Ge, C., Zheng, L., Jin, L., & Zhao, D. (2026). Research progress on active ingredients of traditional Chinese medicine in the treatment of asthenozoospermia. Frontiers in Reproductive Health, 8. https://doi.org/10.3389/frph.2026.1837460

Vancouver

Wang H, Ge H, Ge C, Zheng L, Jin L, Zhao D. Research progress on active ingredients of traditional Chinese medicine in the treatment of asthenozoospermia. Frontiers in Reproductive Health. 2026;8. doi:10.3389/frph.2026.1837460

BibTeX
@article{Wang2026,
  author = {Wang, Hongyu and Ge, Haichao and Ge, Chunyan and Zheng, Lianwen and Jin, Lianhai and Zhao, Donghai},
  title = {Research progress on active ingredients of traditional Chinese medicine in the treatment of asthenozoospermia},
  journal = {Frontiers in Reproductive Health},
  year = {2026},
  volume = {8},
  doi = {10.3389/frph.2026.1837460}
}
Kostenlos starten →